Clinical Trials Logo

Filter by:
NCT ID: NCT00860301 Completed - Infantile Colic Clinical Trials

Acupuncture in Infantile Colic

Start date: December 2006
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate whether acupuncture influences: - the rate of infants who still fulfil the colic criterion after three intervention weeks - the time when the infants are crying, fussing or have intense bouts of colicky symptoms

NCT ID: NCT00860080 Completed - Clinical trials for Post-surgery Adhesion Formation

Safety Study Investigating Local Tolerability and Pharmacokinetics of PXL01 in Healthy Volunteers

Start date: March 2009
Phase: Phase 1
Study type: Interventional

The main purpose of this study is to determine whether three different single doses of PXL01 are safe and well tolerated by healthy volunteers. The pharmacokinetic properties of PXL01 (same doses) will also be investigated.

NCT ID: NCT00859729 Completed - Prostate Cancer Clinical Trials

Dose Finding Study of a DNA Vaccine Delivered With Intradermal Electroporation in Patients With Prostate Cancer

Start date: December 2008
Phase: Phase 1/Phase 2
Study type: Interventional

This study will assess the feasibility and safety of vaccination with increasing doses of xenogenic DNA administered intradermally in combination with electroporation in patients with relapse of prostate cancer. The DNA encodes prostate specific antigen (PSA) from Rhesus Macaque (Macaca mulatta), a protein that is 89% homologous to human PSA. The study will also assess the safety and functionality of the DERMA VAX™ (Cyto Pulse Sciences) DNA vaccine delivery system.

NCT ID: NCT00859599 Recruiting - Clinical trials for Diabetic Foot Ulcers

Monochromatic Phototherapy on Diabetic Foot Ulcers

Start date: August 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of monochromatic phototherapy (Biolight®) on foot ulcers in diabetic patients, in comparison of placebo phototherapy as a complementary to standard diabetic foot ulcer therapy. The study initiated with a four week long Run In Period to eliminate spontaneous healing ulcer to be included. Treatment with monochromatic phototherapy (Biolight® or placebo) will be given locally, additional to standard care, three times weekly during the first four weeks and twice weekly the following sixteen weeks or until the ulcer is completely healed, according to a pre-determined treatment plan. The area of the ulcer will be measured once weekly for 20 weeks or until the ulcer is completely healed.

NCT ID: NCT00859352 Completed - Clinical trials for Healthy Male Volunteer

AZD1981 Midazolam CYP4503A Induction Study

Start date: March 2009
Phase: Phase 1
Study type: Interventional

The primary objective of the study is to investigate if the exposure of midazolam is clinically significantly changed by 14 days of exposure to AZD1981 through possible enzyme induction of CYP3A.

NCT ID: NCT00858871 Completed - Clinical trials for Hepato Cellular Carcinoma (HCC)

First Line Hepato Cellular Carcinoma (HCC)

BRISK FL
Start date: May 2009
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the overall survival of brivanib versus sorafenib in subjects with advanced HCC who have not received prior systemic therapy.

NCT ID: NCT00858819 Completed - Clinical trials for Ankylosing Spondylitis

Clinical Trial of Osteoporosis in Ankylosing Spondylitis

Start date: March 2009
Phase: N/A
Study type: Observational

This is an observational study aiming to study the prevalence and risk factors for osteoporosis and vertebral fractures in patients with ankylosing spondylitis attending three Rheumatology clinics in Western Sweden.

NCT ID: NCT00858780 Completed - Clinical trials for Rheumatoid Arthritis

Study Comparing The Effect On Disease Activity When Reducing Or Discontinuing Etanercept In Subjects With RA

DOSERA
Start date: January 2009
Phase: Phase 4
Study type: Interventional

This study involves Rheumatoid Arthritis patients in regular clinical setting who are already on etanercept treatment and are in remission or in a low disease activity (LDA) state, and is intended to identify parameters that can serve as guidance in clinical settings. This study will consider the clinical and radiographic course in subjects when etanercept treatment is tapered or discontinued, and analyze the subjects' experience of disease worsening and the predictive values of clinical parameters, serum biomarkers and imaging on the clinical and radiographic course in different treatment groups. The effect of re-treatment with etanercept at treatment failure will also be studied.

NCT ID: NCT00858650 Completed - Clinical trials for Testosterone Deficiency

Registry of Hypogonadism in Men

RHyMe
Start date: March 2009
Phase: N/A
Study type: Observational

The primary objective of the Registry of HYpogonadism in MEn (RHYME) is to establish and maintain a large, multi-national prospective registry of male patients who have been diagnosed with male hypogonadism (HG), also known as androgen deficiency or testosterone deficiency.

NCT ID: NCT00858286 Completed - Asthma Clinical Trials

A Follow-up Survey to Compare Stable Dosing (SERETIDE) With SYMBICORT, SMART, Maintenance and Reliever Therapy in One Inhaler in Moderate and Severe Asthmatics.

Start date: February 2009
Phase: Phase 4
Study type: Interventional

The purpose with this study is to describe in detail the control or lack of control of asthma, based on two different dosing strategies, regular treatment with SERETIDE in a stable dosing with short acting beta-2 agonists as needed, or maintenance treatment with SYMBICORT and using the same inhaler with SYMBICORT as needed.